Serum concentrations and tissue expression of components of insulin-like growth factor-axis in females with type 2 diabetes mellitus and obesity: The influence of very-low-calorie diet

► We studied mRNA expression of IGF-1 axis components in monocytes and subcutaneous adipose tissue. ► Type 2 diabetic women had increased IGF-1R mRNA expression in peripheral monocytes. ► Type 2 diabetic women had decreased IGF-1R mRNA expression in subcutaneous adipose tissue. ► Caloric restriction...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Molecular and cellular endocrinology 2012-09, Vol.361 (1-2), p.172-178
Hauptverfasser: Touskova, V., Trachta, P., Kavalkova, P., Drapalova, J., Haluzikova, D., Mraz, M., Lacinova, Z., Marek, J., Haluzik, M.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:► We studied mRNA expression of IGF-1 axis components in monocytes and subcutaneous adipose tissue. ► Type 2 diabetic women had increased IGF-1R mRNA expression in peripheral monocytes. ► Type 2 diabetic women had decreased IGF-1R mRNA expression in subcutaneous adipose tissue. ► Caloric restriction increased serum levels and mRNA expression of IGFBP-2 in SCAT. ► Caloric restriction increased mRNA expression of IGFBP-3 in peripheral monocytes. We explored serum concentrations and mRNA expression of insulin-like-growth factor-1 (IGF-1) axis components in subcutaneous adipose tissue (SCAT) and peripheral monocytes (PM) of 18 healthy females, 11 obese non-diabetic females (OB) and 13 obese women with type 2 diabetes (T2DM) examined at baseline and after very-low-calorie diet (VLCD). T2DM women had decreased expression of IGF-1, IGF-1 receptor (IGF-1R), IGFBP-2 (IGF binding protein-2) and IGFBP-3 in SCAT and increased expression of IGF-1R in PM compared to control group. IGF-1R and IGFBP-3 mRNA expression in SCAT of OB was comparable to control group. In T2DM women VLCD increased serum levels and SCAT expression of IGFBP-2 and PM expression of IGFBP-3. We conclude that decreased IGF-1, IGF-1R and IGFBP-3 expression in SCAT and increased IGF-1R expression in PM of T2DM subjects might contribute to changes of fat differentiation capacity and to regulation of subclinical inflammation by PM, respectively. Increased SCAT and circulating IGFBP-2 and IGFBP-3 in PM might participate in metabolic improvements after VLCD.
ISSN:0303-7207
1872-8057
DOI:10.1016/j.mce.2012.04.005